Hookipa Pharma (HOOK) Receives a Buy from H.C. Wainwright
October 26 2022 - 03:45PM
TipRanks
In a report released on October 21, Arthur He CFA from H.C.
Wainwright maintained a Buy rating on Hookipa Pharma (HOOK -
Research Report), with a price target of $8.00. The company's
shares opened today at $1.25.According to TipRanks, He CFA is a
3-star analyst with an average return of 38.0% and a 60.00% success
rate. He CFA covers the Healthcare sector, focusing on stocks such
as Hookipa Pharma, BioAtla, and LAVA Therapeutics.The word on The
Street in general, suggests a Strong Buy analyst consensus rating
for Hookipa Pharma with a $8.50 average price target.
https://www.tipranks.com/news/blurbs/hookipa-pharma-hook-receives-a-buy-from-h-c-wainwright?utm_source=advfn.com&utm_medium=referral
HOOKIPA Pharma (NASDAQ:HOOK)
Historical Stock Chart
From Mar 2023 to Mar 2023
HOOKIPA Pharma (NASDAQ:HOOK)
Historical Stock Chart
From Mar 2022 to Mar 2023
